Tango Therapeutics, Inc. TNGX
- vopimetostat — Pancreatic Cancer Phase 1
- vopimetostat — Non-Small Cell Lung Cancer Phase 1
- TNG456 — Glioblastoma Phase 1
PRMT5 (2 companies · 5 programs)
Companies with an active program directed at PRMT5.
IDEAYA Biosciences, Inc. IDYA
- IDE892 — Non-Small Cell Lung Cancer Phase 1
- IDE892 — Pancreatic Ductal Adenocarcinoma Phase 1